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The prion protein (PrPC) is a cell surface glycoprotein mainly expressed in
neurons, whose misfolded isoforms generate the prion responsible for incurable
neurodegenerative disorders. Whereas PrPC involvement in prion propagation is
well established, PrPC physiological function is still enigmatic despite suggestions
that it could act in cell signal transduction by modulating phosphorylation cascades
and Ca2+ homeostasis. Because PrPC binds neurotoxic protein aggregates with
high-affinity, it has also been proposed that PrPC acts as receptor for amyloid-β
(Aβ) oligomers associated with Alzheimer’s disease (AD), and that PrPC-Aβ binding
mediates AD-related synaptic dysfunctions following activation of the tyrosine kinase
Fyn. Here, use of gene-encoded Ca2+ probes targeting different cell domains
in primary cerebellar granule neurons (CGN) expressing, or not, PrPC, allowed
us to investigate whether PrPC regulates store-operated Ca2+ entry (SOCE) and
the implication of Fyn in this control. Our findings show that PrPC attenuates
SOCE, and Ca2+ accumulation in the cytosol and mitochondria, by constitutively
restraining Fyn activation and tyrosine phosphorylation of STIM1, a key molecular
component of SOCE. This data establishes the existence of a PrPC-Fyn-SOCE
triad in neurons. We also demonstrate that treating cerebellar granule and cortical
neurons with soluble Aβ(1–42) oligomers abrogates the control of PrPC over Fyn
and SOCE, suggesting a PrPC-dependent mechanizm for Aβ-induced neuronal
Ca2+ dyshomeostasis.
Keywords: prion protein, Ca2+, store-operated Ca2+ entry, Fyn kinase, cerebellar granule neurons, Alzheimer’s
disease, Abeta oligomers, STIM1
Abbreviations: Aβ, amyloid-β; AD, Alzheimer’s disease; AEQ, aequorin; CGN, cerebellar granule neurons;
DMSO, dimethylsulfoxide; ER, endoplasmic reticulum; HA, hemagglutinin; KRB, Krebs-Ringer buffer; mRFP,
monomeric red fluorescent protein; NMDA-R, N-methyl-D-aspartate-sensitive glutamatergic receptors; PBS,
phosphate-buffered saline; PM, plasma membrane; PrPC, prion protein; PrP-KO, PrP-knockout; PrP-Tg,
transgenic Tg46; PVDF, polyvinylidene fluoride; SFK, Src Tyr-kinase family; SOC, store-operated channels;
SOCE, store-operated Ca2+ entry; STIM, stromal interaction molecules; VGCC, voltage-gated Ca2+ channels;
WB, Western blot.
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INTRODUCTION
The prion protein (PrPC) is an ubiquitous cell surface protein
mostly expressed in the central nervous system, particularly
at synapses (Um et al., 2012). Although it is now established
that a conformational conversion of PrPC generates the prion,
the infectious particle causing fatal prion diseases in humans
and animals (Prusiner, 1998), the physiological role played
by PrPC is still undefined. However, most of the proposed
functions emphasize an involvement of PrPC in surface receptor
complexes transducing signals beneficial to the cell (Aguzzi
et al., 2008; Linden et al., 2008). Accordingly, electrophysiological
approaches and dye-based Ca2+ measurements in PrP-knockout
(PrP-KO) or prion-infected cells have implicated PrPC in
the regulation of Ca2+ signaling (reviewed in Sorgato and
Bertoli, 2009), which controls a wide range of physiological
processes but also triggers cell death events if the fine Ca2+
tuning is compromised. Convincing evidence of the PrPC-
Ca2+ liaison comes from the physical interaction of PrPC
with a subunit of the N-methyl-D-aspartate (NMDA)-sensitive
glutamatergic receptors (NMDA-R), which reduces Ca2+ entry
into hippocampal neurons and thus protects from glutamate
excitotoxicity (Khosravani et al., 2008). PrPC was also found
to modulate Ca2+ influx in primary cerebellar granule neurons
(CGN) after inducing store-operated Ca2+ entry (SOCE; Lazzari
et al., 2011). SOCE occurs in response to depletion of Ca2+ from
endoplasmic reticulum (ER), which causes the redistribution
of ER luminal Ca2+ sensors (stromal interaction molecules,
STIM1 and 2) into punctate clusters that recruit and activate
the plasma membrane (PM) pore-forming proteins (Orai1-3)
of store-operated channels (SOC; Soboloff et al., 2012). SOC
mediate exclusively Ca2+ currents, which primarily serve to refill
intracellular Ca2+ reservoirs but also to regulate different cell
functions, including programmed cell death (Dubois et al., 2014),
and gene expression (Lalonde et al., 2014) and excitation in
neurons (Hartmann et al., 2014). It is thus reasonable to speculate
that Ca2+ serves to mediate the different cell functions ascribed
to PrPC (Peggion et al., 2011).
It has also been claimed that the alleged receptor function
of PrPC relates to the modulation of phosphorylation cascades,
in particular that governed by Fyn (Linden et al., 2008;
Sorgato et al., 2009), a member of the Src Tyr-kinase family
(SFK) highly expressed in neurons (Um and Strittmatter,
2013). Interestingly, because Tyr-phosphorylation regulates
fundamental components of SOCE (Lopez et al., 2012), and the
pharmacological inhibition, or deletion, of Tyr-kinases reduces
SOCE-induced Ca2+ transients (Lee et al., 2006; Chung et al.,
2007; Zuo et al., 2011) in various cell lines, one can hypothesize a
tripartite connection between PrPC, Fyn and SOCE.
Recently, PrPC was found to act as a cell surface
binding partner for β-enriched protein aggregates, including
amyloid-β (Aβ) oligomers (Laurén et al., 2009) related to
Alzheimer’s disease (AD; Shankar et al., 2008), prions and other
toxic oligomeric protein species (Resenberger et al., 2011). In
this context, the PrPC-Fyn link has been proposed to mediate
the effects of such neurotoxic entities. In particular, the PrPC-
dependent activation of Fyn was identified as central to couple
PrPC-Aβ complexes to NMDA-R redistribution, Ca2+ signaling
alterations, tau hyper-phosphorylation, spine loss and death in
neurons, and AD pathology in mice (Larson et al., 2012; Um
et al., 2012).
To clarify PrPC patho-physiology, in this study we sought to
determine the capacity of PrPC to govern local Ca2+ homeostasis
in primary neuronal cultures after SOCE. We found that
PrPC regulates SOCE and SOCE-related Ca2+ movements in
several cell domains by controling Fyn activation and the Tyr-
phosphorylation of STIM1. We also observed that the control of
PrPC over Fyn and SOCE is subverted by soluble Aβ oligomers,
suggesting that disruption of Ca2+ signaling mediates the PrPC-
dependent effects of Aβ oligomers.
MATERIALS AND METHODS
Animals
We used PrP-KO (line F10) mice and, as control, transgenic
Tg46 (PrP-Tg) mice in which the expression of PrPC at normal
levels was rescued over the PrP-KO genotype (Mallucci et al.,
2002; both strains kindly provided by the M.R.C. Prion Unit,
London, UK). All aspects of animal care and experimentation
were performed in compliance with European and Italian (D.L.
116/92) laws concerning the care and use of laboratory animals.
The authors’ Institution has been accredited for the use of
experimental mice by the Italian Ministry of Health, and by the
Ethical Committee of the University of Padova.
Primary Neuronal Cultures
CGN primary cultures were prepared (from 7 day-old mice
killed by decapitation after anesthesia with methoxyflurane),
cultured and transduced with lentiviral particles as previously
described in Lazzari et al. (2011). Primary cultures of cortical
neurons were obtained from cortices dissected from E18 mouse
embryos. After carefully removing meningeal layers and blood
vessels, the cortical tissue was gently minced and dissociated
mechanically in B27 (2%)-added Hibernate E medium (Gibco).
After centrifugation (180×g, 5 min), cells were suspended in
Neurobasal medium (Gibco) supplemented with B27 (2%),
horse serum (2%), glutamate (25 µM), L-glutamine (0.5 mM),
and gentamycin [0.1 mg/ml (Gibco)], seeded on poly-L-lysine
(100 µg/ml)-coated 13 mm-diameter glass coverslips at a density
of 450,000 cell/cm2, and maintained at 37◦C in a humidified
incubator with 5% CO2. After 48 h, cells were infected with
lentiviral particles and grown as previously described in Lazzari
et al. (2011), except that cytosine-d-arabinofuranoside (10 µM)
was added 72 h, and cells were used for experiments 144 h, after
plating.
Cell Cultures
HeLa and HEK-293T cells were grown in Dulbecco’s modified
Eagle’s medium/High-Glucose (Euroclone), supplemented with
10% fetal bovine serum (Euroclone), 100 U/ml penicillin and
100 µg/ml streptomycin (Euroclone), and maintained at 37◦C in
a humidified incubator with 5% CO2. Twenty four hours before
infection, HeLa cells were seeded onto 13 mm-diameter glass
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coverslips and allowed to grow to 70–80% confluence. For the
production of lentiviral particles, HEK-293T cells were seeded
onto 100 mm-diameter Petri dishes at ∼40% confluence and
transfected 24 h after plating, as described below.
Construction of Lentiviral Vectors for
Aequorins and Cell Transduction
To follow [Ca2+] fluctuations in specific neuronal
compartments, we exploited a lentiviral expression system
to transduce cells with chimeric constructs encoding the
Ca2+-probe aequorin (AEQ) tagged with the influenza
virus hemagglutinin (HA) epitope, and linked to sequences
addressing the protein to the cytosolic domains proximal
to the PM (AEQpm; Marsault et al., 1997; Lazzari et al.,
2011), the bulk cytosol (AEQcyt; Brini et al., 1995), the ER
lumen (AEQer; Montero et al., 1995; Lazzari et al., 2011)
and the mitochondrial matrix (AEQmit; Rizzuto et al., 1992).
Lentiviral vectors for AEQpm, AEQer and AEQmit were
generated as described in Lim et al. (2008) and Lazzari et al.
(2011), using an AEQ mutant with reduced Ca2+ affinity
allowing [Ca2+] measurements up to hundreds of µM (Kendall
et al., 1992). Conversely, a chimeric construct of wild-type
(WT) AEQ fused to the monomeric red fluorescent protein
(mRFP) was used to detect [Ca2+]cyt. To generate the AEQcyt
lentiviral vector, two PCR reactions were performed. In the
first one, the mRFP sequence was amplified without the
stop codon using the pCDNA3-mRFP plasmid (Clontech) as
template, and the following primers: XbaI-mRFP (forward:
CGTCTAGAATGGCCTCCTCCGAGGAC) and mRFP-
BglII (reverse: GAGGCGCCGGTGGAGTG-GAGATCTCG).
In the second PCR, the HA-AEQ cassette was amplified
using the pCDNA1-cytAEQ plasmid (Brini et al., 1995) as
template, and the following primers: BglII-AEQ (forward:
CGAGATCTCGAGCTCAAGCTTTATGA) and AEQ-SalI
(reverse: GGTATCGATAAGCTTGATGTCGACGC). PCR
products were digested with XbaI and BglII (for mRFP), or
with BglII and SalI (for HA-AEQ), and the resulting fragments
were assembled into the XbaI- and SalI-digested backbone
of the lentiviral vector pRRLsin.PPTs.hCMV.GFP.pre in a
three-step ligation reaction, yielding pLV-AEQcyt. Lentiviral
particles were obtained as described previously (Lazzari et al.,
2011). Briefly, HEK-293T cells were co-transfected with one
of the transgene plasmids (pLV-AEQcyt, pLV-AEQmit, pLV-
AEQpm or pLV-AEQer) together with the three packaging
plasmids pMDLg/pRRE, pMD2.VSVG, pRSV-Rev (Naldini
et al., 1996; Lazzari et al., 2011), using the calcium-phosphate
method. After 10 h, the transfection medium was replaced
with fresh culture medium, and after 72 h the culture medium
was collected, and lentiviral particles were harvested by
ultracentrifugation (50,000×g, 2 h), resuspended in phosphate-
buffered saline (PBS; 140 mM NaCl, 2 mM KCl, 1.5 mM
KH2PO4, 8 mM Na2HPO4, pH 7.4) and stored at −80◦C.
Viral titer was assessed by infecting HeLa cells by serial
viral dilutions. Minimal dilutions adequate for obtaining
100% of infected cells were used to infect primary neurons
and HeLa cells. All procedures for the production and use
of lentiviral particles were performed in a biosafety level-2
environment. The expression and correct cellular localization
of the Ca2+ probes were ascertained by immunocytochemical
procedures, as described below and reported in Supplementary
Figure 2.
Measurements of Local Ca2+ Fluxes
The [Ca2+] range that can be reliably measured with the AEQ
probes is defined by the type of AEQ (WT or mutated) and
of the prosthetic group coelenterazine (Coe; normal (Coe-wt)
or modified (Coe-n), Ottolini et al., 2014). The AEQ and Coe
variants used in this work are listed in Supplementary Table 1.
For measuring [Ca2+]pm, [Ca2+]cyt and [Ca2+]mit transients,
cells were firstly incubated (1 h, 37◦C, 5% CO2) with Coe-
wt (5 µM, Santa Cruz Biotechnology, cat. n. sc-205904) in
a modified (Ca2+-free) Krebs-Ringer buffer (KRB, 125 mM
NaCl, 1 mM Na3PO4, 1 mM MgSO4, 5.5 mM glucose, 5 mM
KCl, 20 mM HEPES, pH 7.4) containing EGTA (100 µM)
for simultaneously reconstituting functional AEQ and depleting
intracellular Ca2+ stores. For the reconstitution of AEQer, cells
were firstly incubated (10 min, 37◦C) in the above Ca2+-free
KRB containing EGTA (1 mM), and then incubated (50 min,
4◦C) in Ca2+-free KRB supplemented with EGTA (500 µM),
ionomycin (5 µM, Sigma) and Coe-n (5 µM, AnaSpec, cat. n.
82260).
Coverslips were then placed onto a recording
chamber—equipped with a perfusion system—located into
the luminometer. For the measurements of [Ca2+]pm, [Ca2+]cyt
and [Ca2+]mit, after a 1 min-perfusion step with EGTA
(100 µM)-containing KRB, SOCE was elicited by perfusing cells
with Ca2+ (1 mM)-containing KRB, as previously described
in Lazzari et al. (2011). For measuring [Ca2+]er, cells were
successively perfused with Ca2+-free KRB containing: EGTA
(500 µM, 2 min); EGTA (1 mM) and bovine serum albumin
[BSA 2% (w/v), 3 min]; EGTA (500µM, 2 min); EGTA (100µM,
1 min). CGN were finally stimulated for SOCE by perfusion with
Ca2+ (1 mM)-containing KRB.
If needed, the inhibitors of voltage-gated Ca2+ channels
(VGCC) [nifedipine (10 µM) and NiCl2 (50 µM or 1 mM);
both from Sigma] were added to the perfusing buffer before (1
min) and during VGCC activation. Instead, the SFK inhibitors
[PP2 (10 µM, Tocris) and saracatinib (5 µM, Santa Cruz
Biotechnology)], and the negative control of PP2, PP3 (10 µM,
Santa Cruz Biotechnology), were added during the reconstitution
step, and kept in the perfusion buffer throughout the entire
experiment. With the exception of NiCl2, all the above molecules
were dissolved in dimethylsulfoxide [DMSO 0.1% (v/v)].
AEQ light emission was collected by means of an in-house
built luminometer, equipped with a low-noise photo-multiplier
coupled by an A/D board to a computer-assisted acquisition
system, with a 1 Hz sampling rate (Ottolini et al., 2014).
At the end of the recording, cells were permeabilized and
exposed to saturating Ca2+ concentration by perfusion with
KRB containing digitonin (50 µM, Sigma) and CaCl2 (10 mM).
This allowed the calibration of the recorded light signal with
respect to the total AEQ content, and its conversion into
Ca2+ concentration, using the algorithm and the custom-made
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software previously described in Brini et al. (1995) and Montero
et al. (1995).
Immunocytochemistry
For immunocytochemical analyses, cells were washed in ice-
cold PBS and fixed (20 min, RT) in 2% (w/v) paraformaldehyde
(Sigma) in PBS. After extensive washing in PBS, cells were
permeabilized with Triton X-100 [0.02% (w/v) in PBS, 1 h, RT],
and then incubated (overnight, 4◦C) with a mouse monoclonal
antibody to the HA epitope [HA.11/clone16B12, Covance, cat. n.
MMS-101P (1:250 in PBS)].
Cells were then washed in PBS, and incubated (1 h, 37◦C)
with AlexaFluor 488-conjugated anti-mouse antibody (1:500,
Molecular Probes). Finally, coverslips were washed in PBS,
mounted in Mowiol 40–88 [Sigma, 8% (w/v) in glycerol:PBS
(1:3)] and observed with a confocal microscope system (Leica
TCS SP5), which also allowed the acquisition and analysis of
digital images.
Preparation and Characterization of Aβ
Oligomers
Chemically synthesized human Aβ(1–42) peptides (Keck
Laboratories) were dissolved (1 mg/ml), and incubated (1 h,
RT), in 1,1,1,3,3,3-hexafluoro-2-propanol. The suspension was
divided into solvent-free (by evaporation) aliquots (50 µg) and
stored (−80◦C). Just before use, peptides were dissolved in
NaOH (20 mM, 50 µl), sonicated (15 min on ice), diluted with
PBS (Vf , 250 µl), and centrifuged (14,000×g, 5 min) to remove
insoluble aggregates. After determining their concentration
spectrophotometrically (λ, 214 nm), Aβ(1–42) peptides were aged
(1 h, 37◦C) to form oligomers, and then administered to CGN
or cortical neurons (1 h, 37◦C) during the AEQ reconstitution
step at a final concentration of 5 µM of monomer equivalents.
Routinely, Aβ(1–42) oligomerization was tested by Western blot
(WB). For SDS-PAGE, Aβ(1–42) samples (∼300 ng), subjected,
or not, to the aging protocol, were diluted in a buffer containing
SDS [3% (w/v)], β-mercaptoethanol [1.5% (v/v)], glycerol [7.5%
(w/v)], Coomassie blue G-250 [0.0125% (Serva)], Tris/HCl
(37.5 mM, pH 7.0), and run in a urea (6M)-containing Tris-
Tricine gel [16% (w/v) acrylamide-N,N′-methylenebisacrylamide
(29:1)] (Schägger, 2006). Proteins were then electro-blotted onto
polyvinylidene fluoride (PVDF) membranes [0.22 µm pore size
(Biorad)], which were processed as described below, except for
the blocking solution that contained non-fat dry milk [5% (w/v)]
instead of BSA, and the primary mouse monoclonal antibody to
Aβ(1–42) (Covance, clone 6E10, cat. n. SIG 39320-200).
Lysis of CGN and WB Analysis
To analyze the (activating auto-) Tyr-phosphorylation of SFK
members (p-SFK) and of total neuronal proteins, CGN—treated,
or not, with Aβ oligomers (see above)—were incubated
(1 h, 37◦C, 5% CO2) in KRB [supplemented with CaCl2
(1 mM), or EGTA (100 µM), to ensure protein analysis
under the same conditions used to measure Ca2+ fluxes]
in the absence, or in the presence, of the SFK inhibitors
(PP2 and saracatinib), or PP3 (see above). CGN were
lysed using an ice-cold buffer containing glycerol [10%
(w/v)], SDS [2% (w/v)], Tris/HCl (62.5 mM, pH 6.8),
urea (1.8 M), Na3VO4 (5 mM), and cocktails of protease
and phosphatase inhibitors (Roche). Lysates, whose protein
concentration was determined by a Lowry assay kit (Sigma,
cat. n. TP0300), were then adjusted to an equal protein
concentration using reducing (dithiothreitol, 50 mM) Laemmli
sample buffer (Laemmli, 1970). After boiling (5 min), lysates
were subjected to SDS–PAGE [10% (w/v) acrylamide-N,N′-
methylenebisacrylamide (37.5:1)] and electro-blotted onto PVDF
membranes [0.45 µm pore size (Millipore)], which were
Coomassie-stained to verify equal loading and transfer (and
for subsequent densitometric analyses, see below). PVDF
membranes were then incubated (1 h, RT) with a blocking
solution made of Tris-buffered saline added with Tween-
20 (TBS-T) [0.1% (w/v)] and BSA [3% (w/v)], followed by
addition of the appropriate primary antibody (4◦C, over-
night). In particular, to detect p-SFK, a rabbit polyclonal
antibody (Cell Signaling Technology, cat. n. 2101) to p-
Tyr416 was used. Instead, a mouse monoclonal antibody
(clone P-Y20, Millipore, cat. n. 05-947) was used to detect
the p-Tyr of total neuronal proteins. Simultaneously with
these tests, the total amount of Fyn (in an equal CGN
quantity) was determined using a specific rabbit polyclonal
antibody (Cell Signaling Technology, cat. n. 4023). After three
10 min-washes (with TBS-T), membranes were incubated
(1 h, RT) with a horseradish peroxidase-conjugated anti-
rabbit or anti-mouse IgG secondary antibody (Santa Cruz
Biotechnology, cat. n. sc-2004 and sc-2005, respectively).
Immunoreactive bands were visualized and digitalized by
means of a digital Kodak Image Station, using an enhanced
chemiluminescence reagent kit (Millipore). For densitometric
analyses, band intensities were normalized to the optical
density of the corresponding lanes stained with Coomassie
blue. To quantify the level of active Fyn, the normalized
band intensity of p-SFK was divided by the normalized band
intensity of Fyn. To electrophoretically separate different SFK
members, equal amounts (10 µg) of CGN proteins were
separated onto glycerol (35%)-supplemented SDS-PAGE gels
[8% (w/v) acrylamide-N,N′-methylenebisacrylamide (37.5:1)].
After transferring proteins onto PVDF membranes [0.45 µm
pore size (Millipore)], and the vertical cutting of membranes
into strips, each strip was immunoprobed with a monoclonal
antibody to either Src (Santa Cruz Biotechnology, cat. n. sc-
5266), or Lck (Santa Cruz Biotechnology, cat. n. sc-433), while
a polyclonal antibody was employed to label Lyn (Millipore,
cat. n. 06-207), or Fyn, or p-SFK (indicated above). After
incubation with the appropriate secondary antibody, PVDF
membranes were accurately reconstructed before visualizing the
immunoreactive signals. To detect PrPC, the mouse monoclonal
antibody 8H4 was used (kindly provided by Prof. M.S. Sy, Case
Western University, Cleveland, OH).
Immunoprecipitation of STIM1
CGN—incubated (1 h, 37◦C, 5% CO2) in KRB [supplemented
with EGTA (100 µM) in order to deplete Ca2+ stores]— were
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lysed (30 min on ice) at 1 × 107 cell/ml in a buffer
containing Tris-HCl (20 mM, pH 7.4), NaCl (75 mM), EGTA
(5 mM), Triton X-100 [1% (w/v)], sodium deoxycholate
[1% (w/v)], Na3VO4, (5 mM) and cocktails of protease
and phosphatase inhibitors. Cell lysates were sonicated and
centrifuged (13,000×g, 15 min, 4◦C) to remove insoluble
materials, and the protein content of the collected supernatant
was determined by a bicinchoninic acid-based assay kit
(Thermo Scientific, cat. n. 23227). 300 µg of the supernatant
proteins were then incubated (overnight, 4◦C) with 1.5 µg
of a monoclonal antibody to STIM1 (BD Bioscience, cat.
n. 610954), followed by incubation with protein A-agarose
(15 µl, SantaCruz Biotechnology, cat. n. sc-2001; 4 h, 4◦C).
The immunoadsorbant was centrifuged (4,000×g, 2 min, 4◦C),
washed twice with NaCl (100 mM), EDTA (2 mM), Na3VO4
(1 mM), and Tris-HCl (50 mM, pH 7.4), resuspended in
reducing Laemmli buffer, boiled (3 min) and loaded onto
Mini-protean TGX precast gels (4–15%, Biorad). Proteins were
electro-blotted onto PVDF membranes [0.45 µm pore size
(Millipore)], and immunodetected using, first, the antibody
to p-Tyr (clone P-Y20, see above), and then, after stripping
membranes with a commercial kit (Thermo Scientific, cat.
n. 21059), a rabbit polyclonal antibody to STIM1 (Cell
Signaling Technology, cat. n. 4916). Immunoreactive bands
were visualized as described above, and for densitometric
analyses the p-Tyr band intensity was normalized to that of
STIM1.
Statistical Analysis
Values are reported as mean ± SEM. Data analysis was
performed as described in Lazzari et al. (2011). Statistics were
based on two-sample Student’s t-test, with a p-value< 0.05 being
considered statistically significant.
RESULTS
PrPC Attenuates SOCE and SOCE-Induced
Mitochondrial Ca2+ Uptake
Previously, comparison of primary CGN cultures obtained from
WT and PrP-KO mice has demonstrated that the presence of
PrPC decreases SOCE-induced Ca2+ elevation in the cytosolic
domains proximal to the PM (Lazzari et al., 2011). Here,
we have extended the study to ascertain whether PrPC also
impinges on Ca2+ fluxes in other domains of primary CGN
derived from PrP-KO, and as control, isogenic PrP-Tg mice
(Supplementary Figure 1). Preliminarily, the correct sub-
cellular localization of the differently targeted AEQ probes was
confirmed by immunocytochemical approaches (Supplementary
Figure 2).
Figure 1 reports Ca2+ transients in PM microdomains (A),
the bulk cytosol (B) and the mitochondrial matrix (C) following
SOCE. While these data confirm that PrP-KO CGN are exposed
to higher Ca2+ transients in PM microdomains than PrP-
expressing neurons (Figure 1A), they also highlight that PrP-KO
neurons display a significantly increased Ca2+ rise in the cytosol
(Figure 1B) and in the mitochondrial matrix (Figure 1C). We
argue that the higher Ca2+ levels observed in PrP-KO neurons
are likely to be accounted for by both the more pronounced Ca2+
entry from the extracellular space (Figure 1A), and by the lower
Ca2+-buffering capacity displayed by the ER (Figure 1D).
VGCC are highly abundant in neurons. To exclude their
activation by local membrane depolarization following SOCE,
we stimulated VGCC alone by perfusing neurons with either
25 mM or 125 mM K+ to mimic mild and strong depolarization,
respectively. We found no detectable PM Ca2+ transients
in CGN—expressing or not PrPC—under mild depolarizing
conditions (data not shown). Conversely, the 125 mM K+
solution induced similar (<3 µM) PM Ca2+ peaks in both
CGN types (Figure 1E) that, however, are much smaller
than those observed upon SOCE. A second control envisaged
treating neurons with inhibitors specific to L-type VGCC
[nifedipine (10 µM)], or targeting all VGCC [NiCl2 (50 µM
or 1 mM)]. We found that both inhibitors reduce Ca2+ entry
stimulated by 125 mM K+ irrespective of the CGN genotype
(∼20% inhibition by nifedipine; ∼95% inhibition by 1 mM
NiCl2, Figure 1F). Instead, no significant diminution of PM
Ca2+ peaks was observed in PrP-Tg and PrP-KO CGN when
each inhibitor was added under the conditions employed to
stimulate SOCE (Figure 1G). These results demonstrate that the
contribution of VGCC to the observed Ca2+ transients is, if any,
minimal.
PrPC Controls SOCE through Fyn
Because of multiple reports linking PrPC to Fyn (Mouillet-
Richard et al., 2000; Santuccione et al., 2005; Pantera et al.,
2009), we investigated whether Fyn signaling pathways critically
acted in the observed regulation of PrPC over SOCE. To
inspect its activating auto-phosphorylation, we monitored the
Tyr phosphorylation of SFK (p-SFK), demonstrating that p-SFK
was at higher levels in PrP-KO CGN than in PrP-Tg neurons
both with Ca2+-depleted stores (to trigger SOCE; Figure 2A),
and under basal (i.e., with Ca2+-filled stores) conditions
(Supplementary Figure 3). Albeit Fyn is particularly abundant
in neurons (Um and Strittmatter, 2013), other SFK members
are present (Lck, Lyn, Src, and Yes; Salter and Kalia, 2004).
However, because among all tested SFK members Fyn is the
only one co-migrating with the immunolabelled p-SFK band
(Supplementary Figure 4), we can conclude that the observed
p-SFK (Figure 2A and Supplementary Figure 3) corresponds
to p-Fyn, and consequently, that PrPC downregulates Fyn in
CGN.
As expected, PP2 and saracatinib, two different selective
inhibitors of SFK (but not PP3, the negative control of PP2),
significantly diminish the level of p-Fyn (Figure 2B), and of all
p-Tyr proteins (Figure 2C), in both CGN types. Importantly,
these inhibitors also diminish SOCE-induced PM Ca2+ peaks,
abrogating in this way the difference observed in untreated PrP-
Tg and PrP-KO neurons (Figure 2D). The parallelism between
SOCE and Fyn activations thus demonstrates that PrPC regulates
SOCE by controling the Fyn signaling pathways.
A key issue to unravel was identification of the molecular
mechanizm linking SOCE to the PrPC-dependent control of
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FIGURE 1 | PrPC regulates Ca2+ movements in different cell domains of cerebellar granule neurons (CGN) after stimulation of SOCE. (A–C) PrP-KO
CGN (black) have higher Ca2+ fluxes than control PrP-Tg CGN (gray) in the cytosolic domains proximal to the plasma membrane (PM) (A), the bulk cytosol (B) and
the mitochondrial matrix (C), as measured by the appropriate AEQ probe. Upper panels report the kinetics of local [Ca2+] transients, while the bar diagrams of the
corresponding [Ca2+] peaks are shown in the lower panels. Here and after, the number of replicates (n) is indicated inside each bar diagram. (D) The steady-state
[Ca2+] level in the endoplasmic reticulum (ER) lumen of PrP-KO CGN is significantly lower than in PrP-Tg CGN. In (A–D), SOCE was activated by treating neurons
with the Ca2+ chelator EGTA to deplete Ca2+ reservoirs. (E) Activation of VGCC by the 125 mM K+-depolarizing solution provokes similar [Ca2+]pm transients and
peaks in both CGN genotypes. (F,G) VGCC inhibitors (nifedipine and NiCl2) lower VGCC-induced [Ca2+]pm peaks (F), but leave unchanged those following SOCE
(G). ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 10−5, Student’s t-test.
Fyn. We focused on STIM1, one of the two ER Ca2+-sensor
isoforms responsible for SOCE activation (Muik et al., 2012),
not only because its Tyr-phosphorylation upregulates SOCE
(Lopez et al., 2012), but also because the expression STIM1,
which reaches its higher level in the cerebellum (Klejman et al.,
2009), is predominant over STIM2 in mouse CGN (Lalonde
et al., 2014). To mention also that the protocol of severe Ca2+
store depletion used here to fully activate SOCE is ideal to
engage STIM1, whose Ca2+ affinity is much higher compared to
STIM2 (Hoth and Niemeyer, 2013). Immunoprecipitation assays
showed that, under the above-mentioned conditions, PrP-KO
CGN display significantly more Tyr-phosphorylated STIM1 than
PrP-Tg neurons (Figure 2E).
Aβ(1–42) Oligomers Impair PrPC-Dependent
Control of SOCE through Fyn
Following the hypothesis that PrPC-Aβ interaction could be
crucial for AD-related neuronal impairment (Laurén et al.,
2009; Um and Strittmatter, 2013), we investigated whether
soluble Aβ(1–42) oligomers (Supplementary Figure 5) perturb
the control of PrPC over SOCE by monitoring PM Ca2+
transients. Compared to the untreated counterpart, we found
that addition of soluble Aβ(1–42) oligomers augments PM Ca2+
peaks of PrP-Tg CGN to the same value detected in untreated
PrP-KO CGN (Figure 3A). Because no statistically significant
effect was evident on Aβ-treated PrP-KO CGN, this result
indicates that dysregulation of SOCE by oligomeric Aβ(1–42)
is strictly dependent on the presence of PrPC. Importantly,
an identical PrPC-dependent alteration of SOCE was also
observed in primary cortical neurons (Figure 3B), which are
a primary target of Aβ oligomers in AD (Haass and Selkoe,
2007).
The capacity of Aβ(1–42) oligomers to disturb SOCE only
in PrP-Tg CGN was paralleled by the action on Fyn, because
once again oligomeric Aβ(1–42) increases the level of active Fyn
in these neurons, both under SOCE-activating (Figure 3C) and
basal (Supplementary Figure 6) conditions. This data indicates
that soluble oligomeric Aβ(1–42) increases SOCE by impairing the
PrPC-dependent downregulation of Fyn.
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FIGURE 2 | The Tyr-kinase Fyn is the link between PrPC and SOCE. (A) PrPC reduces the level of active Fyn, as evident from both the representative WB
(upper panel) of PrP-Tg and PrP-KO CGN probed with an antibody to p-SFK or total Fyn (both run in duplicate), under SOCE-activating conditions (Ca2+-depleted
stores), and the corresponding densitometric analysis of p-SFK immunosignals normalized to that of total Fyn (lower panel). Contrary to other neuronal SFK
members (Supplementary Figure 4), the identical apparent mass of p-SFK and Fyn indicates that the Fyn band corresponds to the p-SFK band. Similar results were
obtained under basal conditions, i.e., with Ca2+-filled stores (see Supplementary Figure 3). (B,C) Addition (+) of the SFK inhibitors saracatinib (sara, 5 µM) and PP2
(10 µM), but not of PP3 (10 µM), reduces the level of both p-SFK (B) and total Tyr-phosphorylated (p-Tyr) proteins (C) of CGN compared to the untreated (−)
samples. (B) The upper panel reports a representative WB of the two neuronal genotypes treated with, or without, the SFK inhibitors, and immunostained as in
(A), while the lower panel shows the corresponding densitometric analysis of p-SFK normalized to the band intensity of total Fyn. Veh (vehicle) indicates the control
experiment run in the presence of DMSO (0.1%). (C) The upper panel reports the WB of total p-Tyr proteins present in the two CGN genotypes treated as in
(B). In the corresponding densitometric analysis (lowest panel), the p-Tyr band intensity was normalized to that of the Coomassie blue-stained bands (middle panel).
(D) Only saracatinib and PP2 decrease SOCE-induced [Ca2+]pm peaks, and abrogate the difference observed in control (veh-treated) PrP-Tg and PrP-KO CGN.
(E) STIM1 is more abundantly Tyr-phosphorylated in PrP-KO CGN than in PrP-Tg CGN under SOCE-stimulating conditions. This is evident from the representative
WB (left panel) of immunoprecipitated (IP) STIM1 probed with an antibody to either p-Tyr or total STIM1 (arrow), and from the corresponding densitometric analysis
(right panel) reported as the ratio between the p-Tyr band intensity and the STIM1 band intensity. The arrowhead in the left panels indicates the immunosignal of the
mouse IgG used in the immunoprecipitation assay. On the left of the WB, MW standards are indicated. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, Student’s t-test. The
analysis of the statistical significance (p-value, Student’s t-test) of data for the comparison between different treatments within each PrP genotype (B–D) is reported
in Supplementary Table 2. Other details are as in the legend to Figure 1.
DISCUSSION
By the novel comparison of local Ca2+ oscillations in isogenic
primary CGN expressing, or not, PrPC, we report here that
PrPC restricts the accumulation of Ca2+ in the cytosol and
mitochondria of neurons following SOCE. PrPC accomplishes
this task by limiting SOC-mediated Ca2+ entry and by increasing
Ca2+ uptake by the ER, which likely depends on the capacity
of PrPC to upregulate the expression of the sarco/endoplasmic
reticulum Ca2+-ATPase pump (Lazzari et al., 2011). We inferred
that, within the used experimental paradigms, SOC are the
only Ca2+ channels influenced by PrPC because our control
experiments show that VGCC do not significantly contribute to
the observed Ca2+ fluxes (see also Park et al., 2010), nor that PrPC
changes the activity of VGCC in contrast to previous indications
(Herms et al., 2000; Korte et al., 2003). Irrespective of this aspect,
our results also highlight the considerable capacity of CGN
mitochondria to buffer SOC-mediated Ca2+ influx, undisclosed
in neurons thus far, in accord to the connection between the
mitochondrial Ca2+ uniporter and SOCE observed in mast cells
(Samanta et al., 2014).
Our data emphasize the protective function of PrPC towards
perilous local Ca2+ overloads (Khosravani et al., 2008) that
may undermine neuronal functions and plasticity, especially in
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FIGURE 3 | Soluble Aβ(1–42) oligomers increase SOCE and Fyn
activation in a PrPC-dependent manner. (A,B) Exposure to Aβ(1–42)
oligomers (at a concentration of 5 µM of monomer equivalents) increases the
(Continued)
FIGURE 3 | Continued
[Ca2+]pm peaks only in PrP-expressing CGN (A) and cortical neurons (B) upon
SOCE stimulation, thus abrogating the difference between the two genotypes
observed in the absence of Aβ(1–42) oligomers (cntr). (C) Under
SOCE-triggering conditions, Aβ(1–42) oligomers significantly increase the
auto-phosphorylation of Fyn in PrP-Tg CGN, but not in PrP-KO CGN, nullifying
the difference between the two genotypes observed in the absence of Aβ(1–42)
oligomers (cntr). This is apparent from both the representative WB of
untreated (−), or Aβ(1–42)-treated (+), neurons (upper panel; probed with an
antibody to p-SFK or total Fyn), and the densitometric analysis of the
anti-p-SFK immunosignal normalized to that of total Fyn (lower panel). Similar
results were obtained under basal conditions, i.e., with Ca2+-filled stores (see
Supplementary Figure 6). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 10−5,
Student’s t-test. Other details are as in the legend to Figures 1, 2.
neurodegenerative disorders (Berridge, 2014). Consistent with
this view, while normal SOCE was found to maintain the
structure of mushroom spines (pivotal to learning and memory;
Sun et al., 2014), excessive SOCE was implicated in hypoxia-
induced neuronal death (Berna-Erro et al., 2009). Likewise,
the capacity of PrPC to shape local Ca2+ signals may shed
light into neurodegenerative pathways such as those occurring
during prion infection, where changes in the expression level and
processing of PrPC (Mays et al., 2014) may contribute to Ca2+-
induced neuronal damages.
The PrPC-dependent downregulation of SOCE was also
observed in primary cortical neurons, suggesting that PrPC
controls SOCE and intracellular Ca2+ transients in different
neuronal cell types. In this context, it is to be mentioned that,
although SOCE is a major pathway for Ca2+ entry in non-
excitable cells (Parekh and Putney, 2005), the importance of
SOCE is increasingly recognized also in excitable cells, including
neurons (Moccia et al., 2015), in which its role is just beginning to
be fully deciphered (Majewski and Kuznicki, 2015). In particular,
a recent report suggests that SOCE could also regulate gene
expression through the transcription factor Sp4 (Lalonde et al.,
2014), which is known to contribute to complex neuronal
processes including learning and memory (Zhou et al., 2010).
Our results thus suggest that the modulation of SOCE could
be one of the means connecting PrPC to the different neuronal
functions attributed to the protein.
Mechanistically, we identified Fyn as a molecular
intermediate enabling PrPC to control SOCE in light of
the observed close correlation between Fyn and SOCE:
both are upregulated in the absence of PrPC, while both are
downregulated by selective SFK inhibitors (PP2 and saracatinib).
In addition to the mandatory variation in ER Ca2+ levels,
SOCE is regulated by different mechanizms that include
the glutathionylation and phosphorylation of STIM proteins
(Hawkins et al., 2010; Pozo-Guisado and Martin-Romero,
2013). In particular, the Tyr-phosphorylation of STIM1 by
SFK members increases SOCE (Lopez et al., 2012). We report
here that—under SOCE-triggering conditions—STIM1 is
more Tyr-phosphorylated in PrP-KO than in PrP-expressing
neurons, a result fully consistent with the higher activation
of SOCE and Fyn observed in PrP-KO neurons. Although
the precise site(s) of Tyr-phosphorylation on STIM1 is(are)
unknown, Tyr361 in the cytosolic domain of the protein
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 October 2015 | Volume 9 | Article 416
De Mario et al. PrP-Fyn-SOCE interplay in neurons
appears the most likely target of SFK members. This site was
found to be phosphorylated by mass spectrometry studies
(http://www.phosphosite.org/siteAction.do?id=25755096), is
highly conserved among different mammalian species, and
is also present in STIM2. Further studies will clarify if
Tyr361 is the actual phosphorylation site by SFK and if
this is a mechanizm to functionally regulate both STIM
isoforms.
Multiple indications have implicated Fyn as a downstream
effector of PrPC in the regulation of key cell processes,
ranging from embryogenesis and neuritogenesis to, at large,
neuroprotective signaling (Aguzzi et al., 2008; Linden et al.,
2008). However, while most observations were obtained upon
stimulation of cells [e.g., by antibody-mediated clustering of
PrPC (Mouillet-Richard et al., 2000; Pantera et al., 2009), or upon
binding of PrPC to NCAM (Santuccione et al., 2005)], for the first
time to our knowledge we have shown that PrPC depresses Fyn
activity under basal conditions. This result opens the possibility
that PrPC is constitutively implicated in such a crucial aspect
of cell physiology, and that dysregulation of this function may
be particularly relevant for those disease-related species, like Aβ
oligomers and prions, which have been proposed to exploit PrPC
as surface binding partner for the downstream transduction of
their toxicity (Barton and Caughey, 2011; Wang et al., 2013;
Hirsch et al., 2014).
In AD, both Ca2+ dyshomeostasis (Green and LaFerla, 2008;
Demuro et al., 2010) and aberrant Fyn signaling (Lambert et al.,
1998; Roberson et al., 2011) were indicated to mediate the
deleterious effects of oligomeric Aβ. Accordingly, it was shown
that Fyn, which is part of a super-molecular complex with PrPC
and the metabotropic glutamate receptor 5 (mGluR5, serving
to connect Fyn and PrPC on the opposite sides of the PM), is
activated after Aβ docking to PrPC (Larson et al., 2012; Um
et al., 2012, 2013). We found that exposure to soluble Aβ(1–42)
oligomers disrupts the PrPC-Fyn-SOCE triangle because such a
treatment increases activation of both Fyn and SOCE in PrP-
expressing, but not in PrP-KO, CGN. Importantly, the PrPC-
dependent effect of Aβ oligomers on SOCE was also observed
in cortical neurons that, together with hippocampal neurons,
are the preferential target of Aβ toxicity (Haass and Selkoe,
2007).
Considering the influence of PrPC on Fyn, our findings are
reminiscent of Fyn activation by PrPC cross-linking (Mouillet-
Richard et al., 2000) or PrPC-NCAM clustering (Santuccione
et al., 2005). However, they disclose a different underlying
mechanism, whereby the interaction of PrPC with extracellular
ligands releases the basal block of PrPC on Fyn rather than
the ligand-PrPC complex directly promoting Fyn activation.
Hence, one initial step of oligomeric Aβ(1–42) toxicity could
involve PrPC displacement from the role of sentinel against
neuronal Ca2+ overload. Additional studies are needed to clarify
whether this effect is consequent to a structural modification of
PrPC, or a dislodgment from natural interacting partners, or a
modification of themembrane lipid architecture surrounding the
protein. Likewise, also the link between Fyn and PrPC in CGN
needs to be elucidated. We exclude the involvement of mGluR5
(Um et al., 2013), given that the neurons utilized here do not
harbor detectable amounts of mGluR5 nor respond to archetypal
mGluR5 agonists (unpublished observations).
In conclusion, we report here that exposure of neurons
to oligomeric Aβ(1–42) results in increased activation of Fyn
and SOCE. However, given that PrP-KO mice show no gross
phenotype, nor overt signs of neurodegeneration, the alterations
observed in this work cannot be sufficient to account for
AD pathology. Nonetheless, they could act as necessary events
that, combined with other (PrPC-dependent and/or PrPC-
independent) insults by Aβ oligomers, eventually contribute to
AD-related neuronal damage. Further studies will be necessary
to demonstrate whether Aβ oligomers perturb local Ca2+
fluxes different from SOCE, in particular those arising from
NMDA-R that have already been functionally associated to PrPC
(Khosravani et al., 2008).
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